Central Nervous System Targeted Protein Degraders
Biomolecules · 25.07.2023 · 13 (8) · 1164
DOI: 10.3390/biom13081164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 25.07.2023. Verfasst von Bedwyr Ab Ion Thomas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK. Hauptthemen laut MEDLINE: Central Nervous System, Brain. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coleg Cymraeg Cenedlaethol, Janssen.
Abstract (Originalsprache)
Diseases of the central nervous system, which once occupied a large component of the pharmaceutical industry research and development portfolio, have for many years played a smaller part in major pharma pipelines—primarily due to the well cited challenges in target validation, valid translational models, and clinical trial design. Unfortunately, this decline in research and development interest has occurred in tandem with an increase in the medical need—in part driven by the success in treating other chronic diseases, which then results in a greater overall longevity along with a higher prevalence of diseases associated with ageing. The lead modality for drug agents targeting the brain remains the traditionally small molecule, despite potential in gene-based therapies and antibodies, particularly in the hugely anticipated anti-amyloid field, clearly driven by the additional challenge of effective distribution to the relevant brain compartments. However, in recognition of the growing disease burden, advanced therapies are being developed in tandem with improved delivery options. Hence, methodologies which were initially restricted to systemic indications are now being actively explored for a range of CNS diseases—an important class of which include the protein degradation technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.
- Chemistry Department, Cardiff University, Cardiff CF10 3AT, UK.
ORCID-Profile: Bedwyr Ab Ion Thomas, Simon E Ward
Förderung
- Coleg Cymraeg Cenedlaethol
- Janssen
Zitieren
APA
Thomas, B. A. I., Lewis, H. L., Jones, D. H., & Ward, S. E. (2023). Central Nervous System Targeted Protein Degraders. Biomolecules, 13(8), 1164. https://doi.org/10.3390/biom13081164
Vancouver
Thomas BAI, Lewis HL, Jones DH, Ward SE. Central Nervous System Targeted Protein Degraders. Biomolecules. 2023;13(8):1164. doi:10.3390/biom13081164
BibTeX
@article{Thomas2023,
author = {Thomas, Bedwyr Ab Ion and Lewis, H Lois and Jones, D Heulyn and Ward, Simon E},
title = {Central Nervous System Targeted Protein Degraders},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {8},
pages = {1164},
doi = {10.3390/biom13081164}
}
EUVIMED